World's Top 20 Pharmaceutical Companies Deploy Revolutionary H-Cube(R) From ThalesNano Inc.



    BUDAPEST, Hungary and LONDON and PRINCETON, NJ, July 16 /CNW/ -
ThalesNano Inc. today announced, that within three years from the original
introduction of its H-Cube product, 20 out of the top 20 pharmaceutical
companies have introduced and adopted the technology.
    The H-Cube(R) Continuous-flow Hydrogenation Reactor is a bench-top
standalone hydrogenation reactor, uniquely combining continuous-flow chemistry
with endogenous on-demand hydrogen generation and a disposable catalyst
cartridge system. It allows safe, fast and cost-efficient hydrogenation with
superior yield when compared to conventional methods. The H-Cube and the other
novel Cube series flow reactor systems developed by ThalesNano Inc. are
showing tremendous benefits in the drug discovery process including shorted
development time, increased cost efficiency and reduced environmental impact.
    "Having all of the top 20 pharmaceutical companies as H-Cube users is a
real testimony that the instrument is changing the process of how drugs are
developed and the benefits that can be derived as a result", said Dr. Laszlo
Urge, CEO of ThalesNano Inc. "Our early customers are now using our technology
at multiple sites on four continents. H-Cube has become their first line of
technology for catalytic hydrogenations. After establishing our continuous
process technology in the discovery labs of the life sciences industry we are
moving into the early scale up and full production with the new versions of
the systems."
    Dr. Ferenc Darvas, President and chairman of ThalesNano Inc. said. "It is
clear that our strategy of providing a disruptive technology to the industry
is working. The benefits of these technologies over conventional batch
chemistry include the rapid synthesis of organic compounds, in particular
under until now unrealizable hazardous reaction conditions. Further benefits
include "Green Chemistry" by minimizing waste, energy consumption and raw
material use, lab automation, and rapid scale-up from mg to kg quantities,
which reduces CAPEX and OPEX while speeding time to market."

    For more information please go to: http://www.thalesnano.com

    About ThalesNano Inc.:

    ThalesNano is a world-leading provider of continuous process chemistry
instruments in the rapidly developing market of laboratory and process scale
flow reactors. The company has the widest portfolio of bench-top continuous
process instruments. Its R&D 100 award winning H-Cube(R) continuous-flow
hydrogenation reactor and the pilot plant scale version H-Cube Midi(TM) are
used in hundreds of laboratories in four continents and have become the new
industry standard for hydrogenation.





For further information:

For further information: Laszlo Urge, Ph.D., CEO, e-mail:
ceodirect@thalesnano.com, Telephone: +36-1-880-8500

Organization Profile

THALESNANO NANOTECHNOLOGY INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890